BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18196550)

  • 21. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
    Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
    Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
    Serda RE; Bisoffi M; Thompson TA; Ji M; Omdahl JL; Sillerud LO
    Prostate; 2008 May; 68(7):773-83. PubMed ID: 18247401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
    Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
    Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta.
    Yen CC; Huang YH; Liao CY; Liao CJ; Cheng WL; Chen WJ; Lin KH
    J Mol Endocrinol; 2006 Feb; 36(1):9-21. PubMed ID: 16461923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GAR22: a novel target gene of thyroid hormone receptor causes growth inhibition in human erythroid cells.
    Gamper I; Koh KR; Ruau D; Ullrich K; Bartunkova J; Piroth D; Hacker C; Bartunek P; Zenke M
    Exp Hematol; 2009 May; 37(5):539-548.e4. PubMed ID: 19375645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate.
    Mora GR; Olivier KR; Mitchell RF; Jenkins RB; Tindall DJ
    Prostate; 2005 May; 63(2):198-207. PubMed ID: 15486985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O; Nazarova N; Tuohimaa P
    Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells.
    Pang ST; Hsieh WC; Chuang CK; Chao CH; Weng WH; Juang HH
    J Mol Endocrinol; 2009 Mar; 42(3):205-14. PubMed ID: 19052253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
    Chiang KC; Tsui KH; Chung LC; Yeh CN; Feng TH; Chen WT; Chang PL; Chiang HY; Juang HH
    Sci Rep; 2014 Jul; 4():5511. PubMed ID: 24981574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
    Tsui KH; Feng TH; Chung LC; Chao CH; Chang PL; Juang HH
    Anticancer Res; 2008; 28(4A):1969-76. PubMed ID: 18649734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.
    Li W; Liu X; Wang W; Sun H; Hu Y; Lei H; Liu G; Gao Y
    Prostate; 2008 Sep; 68(12):1354-61. PubMed ID: 18548481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen-Dependent transcriptional regulation of the prostate-specific antigen gene by thyroid hormone 3,5,3'-L-triiodothyronine.
    Zhu W; Young CY
    J Androl; 2001; 22(1):136-41. PubMed ID: 11191079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.
    Chou WY; Ho CL; Tseng ML; Liu ST; Yen LC; Huang SM
    Int J Biochem Cell Biol; 2008; 40(9):1826-34. PubMed ID: 18299245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
    Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Up-regulates the expression of maspin gene in prostate cancer cell line LNCaP].
    Shi P; Chen WW; Hu XY; Yu CX; Zhang PJ; Jiang AL; Zhang JY
    Yao Xue Xue Bao; 2006 Dec; 41(12):1152-6. PubMed ID: 17290611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodialysis modulates gene expression profile in skeletal muscle.
    Shah VO; Dominic EA; Moseley P; Pickett G; Fleet M; Ness S; Raj DS
    Am J Kidney Dis; 2006 Oct; 48(4):616-28. PubMed ID: 16997058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.